NewEdge Advisors LLC Lowers Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

NewEdge Advisors LLC lowered its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.3% in the fourth quarter, Holdings Channel reports. The institutional investor owned 12,442 shares of the medical equipment provider’s stock after selling 294 shares during the period. NewEdge Advisors LLC’s holdings in Intuitive Surgical were worth $6,494,000 as of its most recent filing with the SEC.

Several other hedge funds also recently made changes to their positions in the company. Atala Financial Inc acquired a new position in shares of Intuitive Surgical during the 4th quarter worth $25,000. Berbice Capital Management LLC acquired a new position in Intuitive Surgical during the fourth quarter worth about $26,000. BankPlus Trust Department purchased a new position in Intuitive Surgical in the fourth quarter valued at about $28,000. Hurley Capital LLC acquired a new stake in shares of Intuitive Surgical during the 4th quarter valued at approximately $28,000. Finally, Summit Securities Group LLC purchased a new stake in shares of Intuitive Surgical during the 4th quarter worth approximately $30,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Trading Up 0.3 %

Shares of Intuitive Surgical stock opened at $482.74 on Friday. The company has a fifty day moving average price of $522.23 and a 200 day moving average price of $532.02. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00. The stock has a market cap of $171.94 billion, a price-to-earnings ratio of 75.31, a price-to-earnings-growth ratio of 5.85 and a beta of 1.55.

Insider Buying and Selling

In other news, EVP Robert Desantis sold 11,545 shares of Intuitive Surgical stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the sale, the executive vice president now directly owns 5,224 shares of the company’s stock, valued at approximately $2,607,925.28. The trade was a 68.85 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Brian Edward Miller sold 8,900 shares of the firm’s stock in a transaction that occurred on Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total value of $4,317,123.00. Following the sale, the executive vice president now owns 5,758 shares of the company’s stock, valued at approximately $2,793,033.06. This trade represents a 60.72 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 33,754 shares of company stock valued at $17,691,621. Corporate insiders own 0.70% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on ISRG shares. JPMorgan Chase & Co. lifted their price objective on Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. Truist Financial dropped their target price on shares of Intuitive Surgical from $666.00 to $605.00 and set a “buy” rating for the company in a report on Monday, March 17th. Royal Bank of Canada raised their price objective on shares of Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. Bernstein Bank raised their price target on Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a research report on Monday, January 27th. Finally, Barclays increased their price objective on Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and an average price target of $611.81.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.